For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230127:nRSa0093Oa&default-theme=true
RNS Number : 0093O Induction Healthcare Group PLC 27 January 2023
Induction Healthcare Group PLC
("Induction", the "Company", or the "Group")
Block Listing Six Monthly Return
Induction Healthcare (AIM: INHC), a leading digital health platform driving
transformation of healthcare systems worldwide, makes the following
six-monthly update on its block listing pursuant to AIM Rule 29 and Schedule 6
of the AIM Rules for Companies:
Name of applicant: Induction Healthcare Group PLC
LEI: 213800RY96GCZQW5TP19
Name of scheme: The Induction Healthcare NTA Share Option Plan
Period of return: From: 27/07/2022 To: 26/01/2023
Number and class of securities originally admitted and the date of admission 3,500,000 ordinary shares on 26 July 2021
Balance of unallotted securities under scheme(s) from initial application: 3,103,433
Plus: The amount by which the block scheme(s) has been increased since the Nil
date of the last return (if any increase has been applied for):
Less: Number of securities issued/allotted under scheme(s) during the period: Nil
Equals: Balance under scheme(s) not yet issued/allotted at end of period: 3,103,433
Contact: Louise Torr, Company Secretary
louise.t@inductionhealthcare.com
ENQUIRIES
Induction Via Walbrook PR Ltd: induction@walbrookpr.com
Christopher Samler, Executive Chair
Paul Tambeau, Chief Operating Officer
Singer Capital Markets (Nominated Adviser and Broker) +44 (0)20 7496 3000
Philip Davies
Walbrook PR Ltd induction@walbrookpr.com
Paul McManus / Alice Woodings Mob: +44(0)7980 541 893 / +44 (0)7407 804 654
About Induction - www.inductionhealthcare.com
(http://www.inductionhealthcare.com)
Induction (AIM: INHC) Induction delivers a suite of software solutions through
a single integrated platform that transforms care delivery. Our system-wide
applications help healthcare providers and administrators to deliver care at
any stage remotely as well as face-to-face - giving the communities they serve
greater flexibility, control and ease of access. Purpose-built for integration
with leading Electronic Medical Record (EMR) platforms, our products offer
immediate stand-alone value that becomes even greater when integrated with
pre-existing systems.
Used at scale by national and regional healthcare systems, as well non-health
government services, our applications are relied upon by hundreds of thousands
of clinicians and millions of patients across almost every hospital in the
British Isles.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BLRNKABKQBKDKDB